Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |